Related Experiment Video
Updated: Mar 29, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
[From biomarkers to clinical decision support]
Péter Antal1, József Reiter2, Péter Mátyus3,4
1Méréstechnika és Információs Rendszerek Tanszék, Budapesti Műszaki és Gazdaságtudományi Egyetem Budapest, Pf. 91, 1521.
Biomedical data integration for personalized medicine faces challenges. Probabilistic graphical models help analyze complex biomarker networks, aiding clinical decision-making and drug research.
Area of Science:
- Biomedical informatics
- Computational biology
- Translational medicine
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Statistical Software for Data Analysis and Clinical Trials
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Automated Microbial Diagnostics
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

